NSCEB Monthly Newsletter – November 2026
NSCEB Monthly Newsletter November 2026 As Congress prepares to return to Washington for the final stretch of work this year, you know we’re ready to maximize every opportunity. We continue to see biotech policy as a bipartisan, bicameral priority for members who want to create jobs all over the country, secure our supply chains, and […]
NSCEB Statement on New Outbound Investment Rule that Includes Biotechnology
NSCEB Statement on New Outbound Investment Rule that Includes Biotechnology The NSCEB supports steps to ensure U.S. investments are not supporting technologies that are long term risks to our national security 22 October 2026 FOR IMMEDIATE RELEASE Washington, DC – Today the U.S. Department of Treasury took action on a recommendation from the National Security […]
NSCEB Statement on New FDA Rare Disease Framework Initiative
NSCEB Statement on New FDA Rare Disease Framework Initiative Emerging biotechnologies will not just treat, but cure, rare disease, and a revised regulatory framework can make accessing treatments easier for the patients and families who need them most. 19 October 2026 FOR IMMEDIATE RELEASE Washington, DC – The National Security Commission on Emerging Biotechnology (NSCEB) […]
NSCEB Analysis: Biotechnology to Secure America’s Biofertilizer Supply
NSCEB Analysis: Securing America’s Food Supply with Biotechnology Emerging biotechnologies provides farmers and growers with new alternatives to chemical fertilizers in a time where supply chains are vulnerable to disruption and rising prices. 15 October 2026 Washington, D.C. – Today, the National Security Commission on Emerging Biotechnology (NSCEB) published new analysis exploring how biofertilizers and biostimulants […]
NSCEB Statement on Future of Science Announcements
NSCEB Statement on Future of Science Announcements As biotechnology converges with emerging technologies, American scientific leadership will be essential to our future economic and national security. 9 October 2026 FOR IMMEDIATE RELEASE Washington, DC – Today Today, the National Security Commission on Emerging Biotechnology released a statement from NSCEB Chair Senator Todd Young on the […]
NSCEB Monthly Newsletter – October 2026
NSCEB Monthly Newsletter October 2026 85 days left on our clock here at the NSCEB. Thank you again for being on this incredible ride with us, and don’t take your foot off the gas. Let’s go! -Caitlin NEW! Using Biotechnology to Secure Critical Mineral Supply Chains In September, the NSCEB published new analysis of […]
NSCEB Sees Long-Standing Efforts Focused on Preparing for the Future of Biotech in New York City
NSCEB Sees Long-Standing Efforts Focused on Preparing for the Future of Biotech in New York City Organizations with deep roots in research and education are expanding the scientific foundation for biotech discovery and building a workforce prepared for the AIxBio future. 28, September 2026 FOR IMMEDIATE RELEASE New York, New York – On Friday, the […]
Oregon’s Foundational Biotech Landscape Leading Next Generation Innovation in the Pacific Northwest
Oregon’s Foundational Biotech Landscape Leading Next Generation Innovation in the Pacific Northwest Home to some of the country’s earliest biotech leaders, Oregon illustrates how a mature innovation ecosystem can help the United States lead in emerging biotechnology. 28, September 2026 FOR IMMEDIATE RELEASE Portland, Oregon – On Friday, the National Security Commission on Emerging Biotechnology (NSCEB) […]
New Bills Designate Biotechnology, Biomanufacturing, and Biological Data as Critical Infrastructure
New Bills Designate Biotechnology, Biomanufacturing, and Biological Data as Critical Infrastructure Despite its growing significance to national security and the economy, the federal government does not adequately protect biotechnology infrastructure or sensitive biological data. 24 September 2026 FOR IMMEDIATE RELEASE Washington, DC – Today, a bipartisan and bicameral group of lawmakers introduced two bills that would require the Cybersecurity and Infrastructure […]
Protecting Biotechnology, Biomanfacturing, and Biological Data as Critical Infrastructure
Protecting Biotechnology, Biomanfacturing, and Biological Data as Critical Infrastructure The Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act would require the Cybersecurity and Infrastructure Security Agency (CISA) to protect biotechnology and biomanufacturing infrastructure by establishing coverage mechanisms for cross-sector infrastructure that do not neatly fall within the current Critical Infrastructure Sectors designations. The Protecting Biological […]
